Alpha-9 Oncology, Inc.
Member Profile
Alpha-9 Oncology is a clinical-stage biopharmaceutical company founded in 2019 by renowned scientists based at BC Cancer and the University of British Columbia.
The Company is using its world-class know-how in molecular design and targeting of radiotherapeutics to advance a portfolio of breakthrough technologies focused on the precision targeting of metastatic cancer. These technologies promise to potentially revolutionize the way in which metastatic cancer is both diagnosed and treated.
Sector
Biotechnology, Diagnostics, Medical Technology , Therapeutics
Biotechnology, Diagnostics, Medical Technology , Therapeutics
Area of Expertise
- Imaging
- Oncology
- Radio Pharmaceuticals
- Therapeutics
Company Stage Clinical
Investment Stage
Private Company, Series A
Private Company, Series A
Member Profile
Biotechnology, Diagnostics, Medical Technology , Therapeutics
Alpha-9 Oncology, Inc.
Bronze Sponsor
- Website www.alpha9tx.com
- Email info@alpha9tx.com
- Address
27 East 7th Ave, Suite 300
Vancouver, BC
V5T 1M4 - Leadership Contact
David Hirsch, CEO
October 24, 2024
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
October 15, 2024
Alpha-9 Oncology Appoints Jean-Jacques Bienaimé and Dr. Steven Stein to its Board of Directors
No current content.